Filing Details

Accession Number:
0001437749-19-010054
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-15 16:04:11
Reporting Period:
2019-05-13
Accepted Time:
2019-05-15 16:04:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
810509 Navidea Biopharmaceuticals Inc. NAVB In Vitro & In Vivo Diagnostic Substances (2835) 311080091
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1554593 Jed Latkin 4995 Bradenton Ave., Suite 240
Dublin OH 43017
Ceo, Coo & Cfo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-13 2,400 $1.91 6,450 No 4 P Direct
Common Stock Acquisiton 2019-05-14 2,000 $1.84 8,450 No 4 P Direct
Common Stock Acquisiton 2019-05-15 1,000 $1.45 9,450 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct